In 2020, there were nearly 74 million children and adolescents in the United States. (U.S. Census Bureau)
Children and adolescents make up approximately 24% of the US population. (U.S. Census Bureau)
PCORI has funded about 103 studies and projects that focus on health conditions or health topics that are highly relevant to children adolescents, or their caregivers, or emerging adults. (As of February 2022)
PCORI Funding Announcements (PFAs): Accepting LOIs Now
View open PFAs for research studies focused on, or related to children's health. LOIs are due on February 7, 2023 by 5:00 pm ET.
Enhancing the Delivery of Mental Health Services to Children in Underserved Areas
While many individuals have come to rely on telehealth services as a way to receive mental health care during the COVID-19 pandemic, children in lower-income families have experienced barriers to mental health care access that existed prior to the pandemic, and in many ways were exacerbated by it.
This PCORI Story highlights findings from a PCORI-funded study in Seattle that was designed to address these parents’ concerns using telehealth platforms and the community partnerships that came out of it.
Report Evaluates Treatments for Infantile Epilepsies
Uncontrolled seizures in children up to 36 months old have serious short-term health risks and may be associated with substantial developmental, behavioral, and psychological impairments.
A systematic review, Management of Infantile Epilepsies, supported by PCORI through a research partnership with the Agency for Healthcare Research and Quality, evaluates the effectiveness, comparative effectiveness, and harms of several treatments for infantile epilepsies.
The main findings of the review include the following: Levetiracetam may be effective in increasing seizure freedom. Ketogenic and modified Atkins diets may reduce seizure frequency. Surgical procedures (Hemispherectomy/Hemispherotomy and Non-Hemispheric procedures) may lead to seizure freedom in some infants.
Evidence for Decisions from PCORI-Funded Studies
Choosing the Best Option for Managing Mild Persistent Asthma in Children
Asthma is a common chronic illness among children in the US, with disproportionate impact among racial and ethnic minorities. A PCORI-funded study, which focused exclusively on African-American children, who have traditionally been underserved in research and have had worse asthma-related health outcomes than other children, looked at two different approaches to managing mild persistent asthma.
A pair of Evidence Updates is now available to help support conversations between parents and clinicians about choosing the best option for managing mild persistent asthma in children.
Study Results that Support Better-Informed Decisions
Telehealth-Based Referrals Improve Access to Hearing Care for Children in Rural Areas
Children in school-based hearing screening programs who received telehealth-based specialist referrals experienced follow-up care up to 17.6 times faster, compared with children who received standard primary care referrals, according to results from the PCORI-funded Hearing Norton Sound Study published in Lancet Global Health. The randomized controlled trial with about 1,500 children in Alaska was led by Susan D. Emmett, MD, MPH, and Samantha Kleindienst Robler, PhD, AuD, from the Center for Hearing Health Equity at the University of Arkansas for Medical Sciences.
The study, which was conducted in 15 rural Alaskan communities between 2017 and 2020, is considered to be the first to demonstrate that telemedicine can reduce a key rural health disparity in access to care. The researchers also suggest that the benefits of telemedicine could translate to other preventive school-based services to improve specialty health care for children in rural areas.
Informing Treatment of Juvenile Arthritis
Clinicians and patients have been uncertain about the optimal time to start biologics for polyarticular juvenile idiopathic arthritis (pJIA). However, results from a PCORI-funded study, published in Arthritis & Rheumatology, provide useful new evidence about first-line treatment options for this disease. Researchers compared the effectiveness of three treatment approaches among 400 children with pJIA.
The approaches included starting patients on a non-biologic disease-modifying antirheumatic drug (DMARD) only, starting patients with a DMARD and a biologic medication, and starting patients with a biologic only. After one year, the approaches did not differ significantly in achieving clinically inactive disease without the use of glucorticoids, and patients reported decreased pain interference levels and increased mobility with all three approaches.
The Effect of Treatment Duration for Newborn Infants Who Have Seizures
Every year, about 16,000 newborns in the United States have seizures. Medications can treat seizures but can also have serious side effects and may harm children’s brain development. A PCORI-funded study at University of Michigan compared functional development outcomes of 270 newborns who developed seizures due to acute brain injury in the first days to weeks after birth and were treated with antiseizure medication (ASM) prior to hospital discharge and those who continued ASM after hospital discharge.
Reporting in JAMA Neurology, the study found that after two years, children in both groups did not differ significantly in their functional development and risk of epilepsy. These results support discontinuation of ASM prior to hospital discharge for most newborns with acute symptomatic neonatal seizures.
Children's Health Study Spotlights
Narrow- versus Broad-Spectrum Antibiotics for Common Infections in Children
When bacteria cause an ear, nose, or throat infection in children, a clinician may prescribe narrow- or broad-spectrum antibiotics. This study found that narrow-spectrum antibiotics worked just as well as broad-spectrum antibiotics. Also, children taking narrow-spectrum antibiotics had fewer side effects than children taking broad-spectrum antibiotics.